1. Home
  2. AREN vs EPIX Comparison

AREN vs EPIX Comparison

Compare AREN & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • EPIX
  • Stock Information
  • Founded
  • AREN 2016
  • EPIX 2009
  • Country
  • AREN United States
  • EPIX Canada
  • Employees
  • AREN N/A
  • EPIX N/A
  • Industry
  • AREN Medical/Dental Instruments
  • EPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • EPIX Health Care
  • Exchange
  • AREN Nasdaq
  • EPIX Nasdaq
  • Market Cap
  • AREN 64.1M
  • EPIX 65.3M
  • IPO Year
  • AREN N/A
  • EPIX N/A
  • Fundamental
  • Price
  • AREN $4.83
  • EPIX $1.77
  • Analyst Decision
  • AREN
  • EPIX Hold
  • Analyst Count
  • AREN 0
  • EPIX 3
  • Target Price
  • AREN N/A
  • EPIX $2.00
  • AVG Volume (30 Days)
  • AREN 224.8K
  • EPIX 235.8K
  • Earning Date
  • AREN 04-15-2025
  • EPIX 05-13-2025
  • Dividend Yield
  • AREN N/A
  • EPIX N/A
  • EPS Growth
  • AREN N/A
  • EPIX N/A
  • EPS
  • AREN N/A
  • EPIX N/A
  • Revenue
  • AREN $125,907,000.00
  • EPIX N/A
  • Revenue This Year
  • AREN $275.98
  • EPIX N/A
  • Revenue Next Year
  • AREN N/A
  • EPIX N/A
  • P/E Ratio
  • AREN N/A
  • EPIX N/A
  • Revenue Growth
  • AREN N/A
  • EPIX N/A
  • 52 Week Low
  • AREN $0.56
  • EPIX $1.40
  • 52 Week High
  • AREN $2.94
  • EPIX $7.88
  • Technical
  • Relative Strength Index (RSI)
  • AREN 88.80
  • EPIX 62.93
  • Support Level
  • AREN $2.34
  • EPIX $1.42
  • Resistance Level
  • AREN $2.94
  • EPIX $1.91
  • Average True Range (ATR)
  • AREN 0.46
  • EPIX 0.09
  • MACD
  • AREN 0.27
  • EPIX 0.03
  • Stochastic Oscillator
  • AREN 94.91
  • EPIX 72.16

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

Share on Social Networks: